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A30開year-oldfemale received living donor kidney transplantation from her mother. The surgical 
procedure was uneventfully performed and urine output was observed a few minutes after reperfusion 
However， 24 hours after the surgery， the urine volume rapidly decreased with worsened renal blood 
flow as determined by Doppler ultrasonography， diagnosed as accelerated acute rejection (AAR) 
Plasma exchange (PE) combined with therapies including administration of steroids and OKT3 
dramatically improved the renal status， resulting in maintenance of good renal function (serum Cr; 1.5 
mg/dl) even after 18 months. PE was considered as a powerful tool for AAR， and the literature was 
reviewed. 
(Hi町 okikaKiyo 51・325-329，2005) 




















3.0 mg/dl， BUN 55 mg/dl， 24時間クレアチニンクリア
ランス (24h-CCr)18.2ml/minと腎機能の低下を認め
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Table 1. 




OKT3 (5 mg/day) 
MMF (1.5 g/day) 
CyA (200 mg/day) 
Immunosuppressive therapy 
X2 days (POD3， 4)
X2 days (POD8， 9)
X 14 days (POD3-10， 11-16) 
X 10 days (P0D3-12) 
POD3-
PODIO-
* PE=plasma exchange， DFPP=double filtered 
plasmapheresis， MP=methylprednisolone， OKT3= 
monoclonal CD3 antibody， MMF=mycophenolate 
mofetil， CyA=cyclosporine A. 
換液として PEを，術後8，9日目に DFPP(double 
filtered plasmapheresis)を施行したさらに，術後3
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PODO POD1 POD2 POD3 POD4 POD5 POD6 POD7 POD8 POD9 POD10 POD11 POD12 
↓↓ 
Post renal transplantation 
Fig. 2. Clinical course during accelerated acute r司ection.
Table 2. Reported cases of accelerated acute rejection treated with plasma exchange 
発症 POD 主な治療 奏功症例/全症例 奏功症例の予後 文献
1-54 PE MP ATG 20/28 IY生着 Aichberge8)， 1997 
1-3 PPATG 2/ 2 S-Cr 2.6/3.7 Loss9)， 1998 
6-20 PE MP OKT3 5/ 5 S-Cr 1.2i:O.3 Pascual2)‘1998 
2-30 PP MP IVIG 13/14 S-Cr 1.4士0.8 MontgomeryIO)， 2000 
7，9 PP MPDSPG 2/ 2 S-Cr 1.2， HD離脱 Takeda1)，2000 
PP MP OKT3 1/1 S-Cr l.l Madan3)， 2000 
5-22 PE MP OKT3 16/19 生着 GuptaI2)，2001 
9 PE MP OKT3 1/1 S-Cr l.l Shimizul3) ， 2002 
<90 PE IVIG 13/15 IY生着 Rocha 6)， 2003 
2 PE MP OKT3 1/1 S-Cr 1.0 This Case， 2002 
* POD=postoperative day. PE=plasma exchange， PP=plasmapheresis， MP=methyl prednisolone， 























反映する PI値， RI値が著明に改善しており， PEは
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